Key result
The FRET-based biosensor Camui allowed spatiotemporally resolved measurement of CaMKII activation state in living rabbit cardiomyocytes, showing activation by pacing and neurohormonal agonists.
The FRET-based biosensor Camui allows for spatiotemporally resolved measurement of CaMKII activation mechanisms in living cardiomyocytes.
Enables dynamic CaMKII studies in intact cardiomyocytes; extends experimental tools but leaves clinical translation open.
RATIONALE: Calcium/calmodulin-dependent protein kinase II (CaMKII) is a key mediator of intracellular signaling in the heart. However, the tools currently available for assessing dynamic changes in CaMKII localization and activation in living myocytes are limited. OBJECTIVE: We use Camui, a novel FRET-based biosensor in which full-length CaMKII is flanked by CFP and YFP, to measure CaMKII activation state in living rabbit myocytes. METHODS AND RESULTS: We show that Camui and mutant variants that lack the sites of CaMKII autophosphorylation (T286A) and oxidative regulation (CM280/1VV) serve as useful biosensors for CaMKIIδ activation state. Camui (wild-type or mutant) was expressed in isolated adult cardiac myocytes, and localization and CaMKII activation state were determined using confocal microscopy. Camui, like CaMKIIδ, is concentrated at the z-lines, with low baseline activation state. Camui activation increased directly with pacing frequency, but the maximal effect was blunted with the T286A, consistent with frequency-dependent phosphorylation of CaMKII at T286 mainly at high-frequency and high-amplitude Ca transients. Camui was also activated by 4 neurohormonal agonists. Angiotensin II and endothelin-1 activated Camui, largely through an oxidation-dependent mechanism, whereas isoproterenol- and phenylephrine-mediated mechanisms had a significant autophosphorylation-dependent component. CONCLUSIONS: Camui is a novel, nondestructive tool that allows spatiotemporally resolved measurement of CaMKII activation state in physiologically functioning myocytes. This represents a first step in using Camui to elucidate key mechanistic details of CaMKII signaling in live hearts and myocytes.
No takes yet. Share an insight, caveat, or question.
Erickson et al. (2011) studied this question. Camui (FRET-based biosensor) was evaluated on CaMKII activation state. The FRET-based biosensor Camui allowed spatiotemporally resolved measurement of CaMKII activation state in living rabbit cardiomyocytes, showing activation by pacing and neurohormonal agonists.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: